Navigation Links
Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials
Date:5/7/2010

Leading Clinical Research Center Announces State-of-the-Art Overnight Facility

Garden City, NY (PRWEB) May 7, 2010 - Accumed Research Associates recently announced their continued growth by providing sleep study as well as overnight phase I and bioequivalence capabilities. Accumed, a leading clinical trials facility in Garden City, NY, now offers opportunities for all phases of clinical research with a well-equipped, state-of-the-art overnight facility for conducting clinical trials.

With more than nine years experience in all phases of clinical research studies, Dr. Mitchell Efros explained, “We wanted to become a complete research site and be able to deliver data in all aspects and phases of clinical trial research.” Dr Efros continued, “We expanded to include phase 1 and bioequivalence studies and are able to provide five associated physicians, two Nurse Practitioners as well as a Physician Assistant for our studies.”

Accumed has an extensive research database. Three research coordinators have more than16 years of combined research experience and support staff includes a data manager and regulatory specialist.

Many sponsors as well as contract research organizations (CRO’s) have utilized the expertise of Accumed and Dr. Efros for future direction and consultation. Accumed has over enrolled in more than 90% of recent trials conducted and has been the top enroller in a number of studies with enrollment performance status consistently at more than 95%.

Dr. Efros founded Accumed in 2001 and has successfully conducted more than 100 clinical trials. Accumed has become a well-known research center both in the local community and the industry due to its reputation for extensively trained employees who are dedicated to the highest standards of patient care. The site prepares for all monitoring visits and allots adequate time for the contract research associates (CRAs).

Dr. Efros and Accumed Research Associates are affiliated with the following prestigious research and medical organizations: Association of Clinical Research Professionals, Fellow of American College of Surgeons, American Urologic Association and American Association of Clinical Urologists.

Accumed Research Associates (http://www.AccumedResearch.com) is located in Garden City, NY on Long Island, and is a leader in clinical trials and studies. With more than nine years of experience in all phases of clinical research, Accumed Research Associates has access to a large research database and can prospectively identify suitable candidates for their clinical studies. The company’s strength includes its extensively trained employees dedicated to the highest standards of patient care as well as a state-of-the-art comprehensive facility, and research department.

# # #

Read the full story at http://www.prweb.com/releases/2010/05/prweb3945764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Accumed Research Associates Launches Official Website
2. New research identifies modifiable risk factors for heart disease
3. Nuvo Research announces early redemption of 5% convertible debentures
4. Researcher to track spread of disease, malware and power outages
5. UCSF Researchers Identify Regulator of Human Sperm Cells
6. Octapharma Accepting Applications for Research Grants Through March 31
7. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
8. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
9. University of Maryland chemist receives Astellas Award for blindness prevention research
10. Developing a cyberinfrastructure for comparative effectiveness in cancer research
11. Women should be allowed to eat, drink during labor: Queens University researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... SyncDog, Inc. , the ... partners LG Business Solutions at ATARC Federal Mobile Computing Summit , March ... provide education and examination into the mobility tools and technology employed by the ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Case Management Society of America (CMSA) ... 30, 2017. CMSA’s membership has elected their upcoming President-Elect, Secretary, Treasurer and two ... position, a new VA Advisory position has also been added to the BOD, per ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... training, today announced the launch of a new research study, The Business Readiness ... needed to execute that strategy, and the actual success of achieving individual and ...
(Date:3/27/2017)... ... 2017 , ... Janet Schloz is still in shock after receiving a $2,500 Academic Award from ... long time,” she said. , She thinks the coming week is going to be a ... would have to help my students.” , The award will allow the 4th grade teacher ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... announce the launch of a months-long rebranding effort. This includes the introduction of ... focus group discussions and market research, we learned that a simple, proactive approach ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
Breaking Medicine Technology: